@article{9a12ea8be6074f54b95ba84c37c56082,
title = "Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (Nature Cancer, (2025), 6, 3, (528-539), 10.1038/s43018-025-00921-6)",
abstract = "Correction to: Nature Cancerhttps://doi.org/10.1038/s43018-025-00921-6, published online 17 March 2025.",
author = "\{on behalf of the ELM-2 Investigators\} and Kim, \{Won Seog\} and Kim, \{Tae Min\} and Cho, \{Seok Goo\} and Isidro Jarque and El{\.z}bieta Iskierka-Ja{\.z}d{\.z}ewska and Poon, \{Li Mei\} and Prince, \{H. Miles\} and Huilai Zhang and Junning Cao and Mingzhi Zhang and Beno{\^i}t Tessoulin and Oh, \{Sung Yong\} and Francesca Lim and Cecilia Carpio and Tan, \{Tran Der\} and Sabarish Ayyappan and Antonio Gutierrez and Jingxian Cai and Melanie Ufkin and Saleem Shariff and Jurriaan Brouwer-Visser and Aafia Chaudhry and Hesham Mohamed and Srikanth Ambati and Jan Walewski and Umar Farooq and Andreas Klein and Farrukh Awan and Don Stevens and Rakhee Vaidya and Villasboas, \{Jose C.\} and Jon Arnason and Parameswaran Venugopal and Lori Leslie and Deepa Jagadeesh and Sami Ibrahimi and Thomas Jandl and John Allan and Nagah Elmusharaf and David Lewis and David Tucker and Andrea Kuhnl and David Cunningham and Wang, \{Ming Chung\} and Wu, \{Shang Ju\} and Yeh, \{Su Peng\} and Chen, \{Tsai Yun\} and Sara Miqueleiz and Eva Gonzalez-Barca and Mun, \{Yeung Chul\}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",
year = "2025",
month = may,
doi = "10.1038/s43018-025-00967-6",
language = "English",
volume = "6",
pages = "907",
journal = "Nature Cancer",
issn = "2662-1347",
publisher = "Nature Research",
number = "5",
}
